JoAnne Zujewski

2.0k total citations
20 papers, 440 citations indexed

About

JoAnne Zujewski is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, JoAnne Zujewski has authored 20 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Genetics and 8 papers in Cancer Research. Recurrent topics in JoAnne Zujewski's work include Breast Cancer Treatment Studies (8 papers), Estrogen and related hormone effects (6 papers) and BRCA gene mutations in cancer (5 papers). JoAnne Zujewski is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Estrogen and related hormone effects (6 papers) and BRCA gene mutations in cancer (5 papers). JoAnne Zujewski collaborates with scholars based in United States, Finland and Belgium. JoAnne Zujewski's co-authors include David Venzon, Catherine K. Chow, Ahalya Premkumar, Joyce O’Shaughnessy, Elizabeth C. Jones, Maria J. Merino, David N. Danforth, Jennifer Eng‐Wong, Linda C. Harlan and Lindsey Enewold and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

JoAnne Zujewski

20 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JoAnne Zujewski United States 12 224 208 123 120 97 20 440
Leila Dorling United Kingdom 12 204 0.9× 212 1.0× 127 1.0× 146 1.2× 109 1.1× 18 541
Monica Jernberg Engstrøm Norway 11 273 1.2× 242 1.2× 72 0.6× 58 0.5× 67 0.7× 21 472
Alexandra J. van den Broek Netherlands 12 224 1.0× 317 1.5× 76 0.6× 54 0.5× 251 2.6× 18 562
Nirmala Pathmanathan Australia 14 245 1.1× 273 1.3× 63 0.5× 95 0.8× 39 0.4× 40 553
JA Bell United Kingdom 7 370 1.7× 250 1.2× 59 0.5× 107 0.9× 80 0.8× 9 577
Liisa Sailas Finland 7 260 1.2× 179 0.9× 121 1.0× 48 0.4× 33 0.3× 11 412
Maggie Wilcox United Kingdom 6 340 1.5× 304 1.5× 168 1.4× 42 0.3× 51 0.5× 9 512
J. Mihura France 9 216 1.0× 166 0.8× 50 0.4× 37 0.3× 66 0.7× 15 344
Bianca Lederer Germany 13 415 1.9× 348 1.7× 119 1.0× 64 0.5× 42 0.4× 39 646
Antonia Márquez Spain 10 294 1.3× 134 0.6× 99 0.8× 71 0.6× 24 0.2× 15 444

Countries citing papers authored by JoAnne Zujewski

Since Specialization
Citations

This map shows the geographic impact of JoAnne Zujewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JoAnne Zujewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JoAnne Zujewski more than expected).

Fields of papers citing papers by JoAnne Zujewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JoAnne Zujewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JoAnne Zujewski. The network helps show where JoAnne Zujewski may publish in the future.

Co-authorship network of co-authors of JoAnne Zujewski

This figure shows the co-authorship network connecting the top 25 collaborators of JoAnne Zujewski. A scholar is included among the top collaborators of JoAnne Zujewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JoAnne Zujewski. JoAnne Zujewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zujewski, JoAnne, et al.. (2020). Patient Advocacy Approaches to Improving Care for Breast and Cervical Cancer in East and Southern Africa. JCO Global Oncology. 6(6). 49–55. 3 indexed citations
3.
Enewold, Lindsey, Ann M. Geiger, JoAnne Zujewski, & Linda C. Harlan. (2015). Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy. Breast Cancer Research and Treatment. 151(1). 149–156. 35 indexed citations
4.
O’Sullivan, Ciara C., Ian Bradbury, Evandro de Azambuja, et al.. (2014). Efficacy of adjuvant trastuzumab (T) compared with no T for patients (pts) with HER2-positive breast cancer and tumors ≤ 2cm: A meta-analysis of the randomized trastuzumab trials.. Journal of Clinical Oncology. 32(15_suppl). 508–508. 5 indexed citations
5.
Chiou, Victoria L., Elise C. Kohn, Christina M. Annunziata, et al.. (2014). Abstract CT337: Phase I/Ib study of the PARP inhibitor (PARPi) olaparib (O) with carboplatin (C) in triple negative breast cancer (TNBC) at low genetic risk (NCT00647062). Cancer Research. 74(19_Supplement). CT337–CT337. 1 indexed citations
6.
Perez, Edith A., Michael F. Press, Amylou C. Dueck, et al.. (2013). Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005). Breast Cancer Research and Treatment. 138(1). 99–108. 63 indexed citations
7.
Lee, Jung‐Min, Christina M. Annunziata, John L. Hays, et al.. (2013). Phase I/Ib study of the PARP inhibitor olaparib (O) with carboplatin (C) in BRCA1/2 mutation carriers with breast or ovarian cancer (Br/OvCa) (NCT00647062).. Journal of Clinical Oncology. 31(15_suppl). 2514–2514. 7 indexed citations
8.
Premkumar, Ahalya, David Venzon, Nilo A. Avila, et al.. (2007). Gynecologic and hormonal effects of raloxifene in premenopausal women. Fertility and Sterility. 88(6). 1637–1644. 14 indexed citations
9.
Zujewski, JoAnne & Jennifer Eng‐Wong. (2005). Sentinel Lymph Node Biopsy in the Management of Ductal Carcinoma In Situ. Clinical Breast Cancer. 6(3). 216–222. 11 indexed citations
10.
Korde, Larissa A., et al.. (2004). Assessing breast cancer risk. Postgraduate Medicine. 116(4). 6–34. 14 indexed citations
11.
Lebowitz, Peter F., Jennifer Eng‐Wong, Sandra M. Swain, et al.. (2004). A Phase II Trial of Neoadjuvant Docetaxel and Capecitabine for Locally Advanced Breast Cancer. Clinical Cancer Research. 10(20). 6764–6769. 30 indexed citations
12.
Danforth, David N., Kenneth H. Cowan, Rosemary M. Altemus, et al.. (2003). Preoperative FLAC/Granulocyte-Colony-Stimulating Factor Chemotherapy for Stage II Breast Cancer: A Prospective Randomized Trial. Annals of Surgical Oncology. 10(6). 635–44. 22 indexed citations
13.
Ellis, Chad A., Michele D. Vos, Christine M. Riley, et al.. (2003). Tamoxifen and the Farnesyl Transferase Inhibitor FTI-277 Synergize to Inhibit Growth in Estrogen Receptor-Positive Breast Tumor Cell Lines. Breast Cancer Research and Treatment. 78(1). 59–67. 28 indexed citations
14.
Lebowitz, Peter F. & JoAnne Zujewski. (2003). Hormonal therapy of breast cancer. Current Problems in Cancer. 27(6). 279–331. 4 indexed citations
15.
Zujewski, JoAnne. (2002). Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention. Environmental and Molecular Mutagenesis. 39(2-3). 264–270. 8 indexed citations
16.
Danforth, David N., Luigi Aloj, Jorge A. Carrasquillo, et al.. (2002). The Role of 18F-FDG-PET in the Local/Regional Evaluation of Women with Breast Cancer. Breast Cancer Research and Treatment. 75(2). 135–146. 61 indexed citations
17.
Zujewski, JoAnne, et al.. (2000). Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system. Breast Cancer Research. 3(1). 66–75. 3 indexed citations
18.
Chow, Catherine K., David Venzon, Elizabeth C. Jones, et al.. (2000). Effect of tamoxifen on mammographic density.. PubMed. 9(9). 917–21. 90 indexed citations
19.
Dunbar, Cynthia E., John F. Tisdale, Toshihiro Soma, et al.. (1997). Transduction of hematopoietic stem cells in humans and in nonhuman primates. Stem Cells. 15(S2). 135–140. 20 indexed citations
20.
Warren, M K, JoAnne Zujewski, Wendy L. Rose, et al.. (1996). Early Suppressive Effects of Chemotherapy on Recovery of Bone Marrow Megakaryocyte Precursors: Possible Relationship to Platelet Recovery. Stem Cells. 14(S1). 31–37. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leila Dorling Breakdown of academic impact, for papers by Monica Jernberg Engstrøm Breakdown of academic impact, for papers by Alexandra J. van den Broek Breakdown of academic impact, for papers by Nirmala Pathmanathan Breakdown of academic impact, for papers by JA Bell Breakdown of academic impact, for papers by Liisa Sailas Breakdown of academic impact, for papers by Maggie Wilcox Breakdown of academic impact, for papers by J. Mihura Breakdown of academic impact, for papers by Bianca Lederer Breakdown of academic impact, for papers by Antonia Márquez
Rankless by CCL
2026